Epsilon Healthcare Limited (ASX:EPN)
Australia · Delayed Price · Currency is AUD
0.0210
-0.0010 (-4.55%)
Mar 25, 2026, 2:51 PM AEST
Revenue by Segment
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Telehealth Medical Practice | 524.86K | 861.26K | 1.23M | 1.45M | - | | | | | |
Telehealth Medical Practice Growth | -39.06% | -30.25% | -14.88% | - | - | | | | | |
Contract Development and Manufacturing | 7.65M | 4.74M | 5.42M | 2.80M | - | | | | | |
Contract Development and Manufacturing Growth | 61.43% | -12.51% | 93.38% | - | - | | | | | |
| 4.90K | - | - | 400.06K | - | | | | | |
| 1.21M | - | - | - | - | | | | | |
Hydroponics Equipment, Materials and Nutrients | - | - | - | - | 2.83M | | | | | |
Hydroponics Equipment, Materials and Nutrients Growth | - | - | - | - | -52.19% | | | | | |
| - | - | - | - | 2.67M | | | | | |
Medicinal Cannabis Growth | - | - | - | - | 158.82% | | | | | |
| 9.39M | 5.60M | 6.65M | 4.65M | 5.50M | | | | | |
| 67.74% | -15.81% | 42.99% | -15.39% | -20.93% | | | | | |
Revenue by Geography
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 5.60M | 6.65M | 4.65M | 2.67M | | | | | |
| -15.81% | 42.99% | 74.47% | -61.66% | | | | | |
| - | - | - | 2.83M | | | | | |
| 5.60M | 6.65M | 4.65M | 5.50M | | | | | |
| -15.81% | 42.99% | -15.39% | -20.93% | | | | | |
Source: S&P Global Market Intelligence.